Life Technologies reported $-367334 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Ardelyx USD -12503000 20.63M Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Cipla INR 15.25B 2.97B Jun/2025
Clal Biotechnology ILS -5438000 3.76M Dec/2022
Compugen USD -8429000 946K Jun/2025
CSL USD 2.75B 1.35B Dec/2024
Galapagos EUR -57027000 101.68M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
Grifols EUR 357.3M 21.62M Sep/2024
Life Technologies USD -367334 15.45M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
United Therapeutics USD 276.9M 105.9M Jun/2025